Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$36.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Evolution of Translational Omics: Lessons Learned and the Path Forward Rare Diseases and Orphan Products: Accelerating Research and Development Other Related Titles Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary (2012) Board on Health Sciences Policy (HSP) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix D: Registered Attendees." Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary. Washington, DC: The National Academies Press, 2012. Please select a format: Page 83   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore Page 83 Front Matter (R1-R20) 1 Introduction (1-4) 2 The Current Landscape (5-16) 3 Case Studies (17-28) 4 Emerging Technologies in Drug Development (29-36) 5 Evolving Paradigms (37-46) 6 Forging Collaborative Strategies for the Development of Personalized Medicine (47-54) References (55-58) Appendix A: Workshop Agenda (59-64) Appendix B: Speaker Biographical Sketches (65-80) Appendix C: Statement of Task (81-82) Appendix D: Registered Attendees (83-90)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 83
Appendix D Registered Attendees Brian Abbott Anahita Bhathena AstraZeneca Pharmaceuticals Abbott Laboratories Nathan Adams Paul Billings Defense Threat Reduction Agency, Life Technologies Department of Defense Bruce Blumberg Margaret Anderson Kaiser Permanante FasterCures Denise Bonds Euan Ashley National Heart, Lung, and Blood Stanford University Institute, National Institutes of Health Christopher Austin National Center for Advancing Ann Bonham Translational Sciences, Association of American Medical National Institutes of Health Colleges Sarah Beachy Kristopher Bough National Cancer Institute, National National Institute on Drug Abuse, Institutes of Health National Institutes of Health Judith Benkendorf Joann Boughman American College of Medical American Society of Human Genetics Genetics 83

OCR for page 84
84 GENOME-BASED THERAPEUTICS Khaled Bouri Nicholas Davies U.S. Food and Drug Administration PricewaterhouseCoopers LLP Linda Brady Silvana Dean National Institutes of Health U.S. Food and Drug Administration Apryl Brown Jamie Driscoll Wayne County Community College National Institute of Mental Health, District National Institutes of Health Wylie Burke Rade Drmanac University of Washington Complete Genomics Walter Capone Deborah Dunsire Multiple Myeloma Research Millennium: The Takeda Oncology Foundation Company Carolyn Carroll Victor Dzau STAT TECH Inc. Duke University Health System Christine Carter Peggy Eastman Society for Women's Health Oncology Times Research Amy Efantis C. Thomas Caskey Boehringer Ingelheim Baylor College of Medicine Pharmaceuticals, Inc. Chia-Chien Chiang Raith Erickson Human Genome Sciences, Inc. Complete Genomics Lisa Chong Cynthia Ewel Science Medco Research Institute Melina Cimler W. Gregory Feero Illumina National Human Genome Research Institute, National Institutes of Sara Copeland Health Health Resources and Services Administration Mandy Field Children's National Medical Center Sean David Stanford University School of Gary Filerman Medicine Atlas Health Foundation

OCR for page 85
APPENDIX D 85 Ross Filice Andrea Giuffrida U.S. Food and Drug Administration National Institutes of Health Kelly Filipski Evan Hadley National Cancer Institute National Institute on Aging, National Institutes of Health Andrew Fish AdvaMedDx Margaret Hamburg U.S. Food and Drug Administration Garret FitzGerald Perelman School of Medicine, Steffan Ho University of Pennsylvania Pfizer Inc. Cathy Fomous Carolyn Hoban National Institutes of Health Multiple Myeloma Research Foundation Richard Forshee U.S. Food and Drug Administration Damon Hostin Complete Genomics Jane Fridlyand Genentech Florence Houn Celgene Felix Frueh Medco Research Institute Kathy Hudson National Center for Advancing Dean Gaalaas Translational Sciences, EdgeBio National Institutes of Health Ron Galloway Sheikh Mohammed Shariful Islam Method Content LLC International Centre for Diarrhoeal Disease Research, Bangladesh John Gardenier Independent Jean Jenkins National Human Genome Research Turkan Gardenier Institute, National Institutes of Pragmatica Corporation Health Fathia Gibril Justin Johnson U.S. Food and Drug Administration EdgeBio Geoffrey Ginsburg Carolyn Jones Duke University Biogen Idec

OCR for page 86
86 GENOME-BASED THERAPEUTICS Thea Kalebic Kathy Kopnisky Millennium: The Takeda Oncology National Institutes of Health Company Courtney Lang Francis Kalush Pepperdine University Center for Devices and Radiological Health, U.S. Food and Drug Thomas Lehner Administration National Institute of Mental Health, National Institutes of Health Sharon Kardia University of Michigan Debra Leonard Weill Cornell Medical Center Nobuko Katagiri U.S. Food and Drug Administration Emily Levy Synergy Partners John Kehne Translational Neuropharmacology Michelle Lewis Consulting LLC Johns Hopkins University John Kenten Len Lichtenfeld Mesoscale Diagnostics American Cancer Society Mohamed Khan Michele Lloyd-Puryear British Columbia Cancer Agency Office of Rare Diseases Research, National Institutes of Health Muin Khoury Centers for Disease Control and Laurence McCarthy Prevention Scientific Technologies & Solutions, LLC Chava Kimchi-Sarfaty U.S. Food and Drug Administration Michael McCaughan RPM Report Roger Klein Esther & Hyman Rapport Robert McCormack Philanthropic Trust Veridex, LLC Hon-Sum Ko Kathryn McLaughlin U.S. Food and Drug Administration Health Resources and Services Administration Susan Koester National Institute of Mental Melodi McNeil Health, National Institutes of Abbott Laboratories Health

OCR for page 87
APPENDIX D 87 Amy Miller Praveen Pendyala Personalized Medicine Coalition Center for Studying Health System Change Helen Moore National Cancer Institute, National Michelle Penny Institutes of Health Eli Lilly and Company Richard Morris Margaret Piper National Institutes of Health BlueCross BlueShield Association Peter Mueller Laura Povlich Vertex Pharmaceuticals U.S. House of Representatives Arnulfo Muralles Aidan Power American Association for the Pfizer Inc. Advancement of Science Arundeep Pradhan Laura Nisenbaum Oregon Health & Science University Eli Lilly and Company Victoria Pratt Lolita O'Donnell Quest Diagnostics Defense Centers of Excellence for Psychological Health and Ronald Przygodzki Traumatic Brain Injury Department of Veterans Affairs Steve Olson Drena Reaves-Bey Independent Consultant Parenting Before Conception Michael Pacanowski Cynthia Reilly U.S. Food and Drug Administration American Society of Health-System Pharmacists Gustavo Palacios Center for Genomic Sciences Jon Retzlaff American Association for Cancer Gary Palmer Research Foundation Medicine Max Robinowitz Lydia Pan U.S. Food and Drug Administration Pfizer Inc. Bob Roehr Gillian Parrish British Medical Journal FasterCures

OCR for page 88
88 GENOME-BASED THERAPEUTICS Allen Roses Ansalan Stewart Duke University U.S. Department of Health and Human Services Deborah Runkle American Association for the Carol Stinson Advancement of Science AstraZeneca Pharmaceuticals Lisa Schlager Katherine Johansen Taber Facing Our Risk of Cancer American Medical Association Empowerment Zivana Tezak Derek Scholes U.S. Food and Drug Administration National Human Genome Research Institute, National Institutes of Barry Thompson Health American College of Medical Genetics Amber Scholz President's Council of Advisors on Javier Torres-Roca Science and Technology H. Lee Moffitt Cancer Center Joan Scott Mark Trusheim National Coalition for Health MIT Sloan School of Management Professional Education in Genetics Kenneth Tucker Tauri Group, Inc. Sam Shekar Northrop Grumman Simona Volpi National Human Genome Research Vijaya Simhadri Institute, National Institutes of Center for Biologics Evaluation Health and Research, U.S. Food and Drug Administration Amelia Warner Merck Tania Simoncelli U.S. Food and Drug Administration Daniel Wattendorf Department of the Air Force Dee Simons Biogen Idec Jill Wechsler Pharmaceutical Executive Magazine James Sorace U.S. Department of Health and Cole Werble Human Services RPM Report

OCR for page 89
APPENDIX D 89 Catherine Wicklund Northwestern University Erin Wilhelm Georgetown University Hui-Hsing Wong U.S. Department of Health and Human Services

OCR for page 90